KIT and myocardial infarction: Furthermore, we provide evidence that intravenous implanted c-kit+AT2R+ BMMNCs are able to infiltrate the heart and are superior to c-kit+AT2R− and unfractionated BMMNCs in supporting cardiomyocyte survival and repressing cardiac inflammation, ultimately improving global heart function and reducing infarct size in the MI mice model.